Biosignificance of bacterial cyanogenesis in the CF lung

Journal of Cystic Fibrosis

Volumn 9, Issue 3, 2010, Pages 158-164

  Anderson, R D ^a,b   Roddam, L F ^a,b   Bettiol, S ^a,b   Sanderson, K ^a,b   Reid, D W ^a,b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cyanogenesis; Cystic fibrosis; Lung; Pseudomonas; Toxicity

Indexed keywords

ALGINATE REGULATOR; ANAEROBIC REGULATOR; BACTERIAL PROTEIN; CYANIDE; GLOBAL ACTIVATOR; HYDROGEN CYANIDE; PROTEIN RHLR; UNCLASSIFIED DRUG;

CYANOGENESIS; CYSTIC FIBROSIS; CYTOTOXICITY; DETOXIFICATION; DISEASE COURSE; HOST CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG INFECTION; NEUTROPHIL; OPERON; OXIDATIVE STRESS; OXYGEN SUPPLY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; UPREGULATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG DISEASE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; TOXICITY;

CYANIDES; CYSTIC FIBROSIS; DISEASE PROGRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG DISEASES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 77953356648     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.12.003     Document Type: Review

References (76)

1. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology 2007, 153:917-923.
2. Armstrong D.S., Grimwood K., Carlin J.B., Carzino R., Olinsky A., Phelan P.D. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996, 21:267-275.
3. Saiman L. Microbiology of early CF lung disease. Paediatr Respir Rev 2004, 5(Suppl A):S367-S369.
4. Bjarnsholt T., Fiandaca M.J., Jensen P.O., Pedersen J., Andersen C.B., Hansen C.R., et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009, 44:547-558.
5. Ryall B., Davies J.C., Wilson R., Shoemark A., Williams H.D. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Eur Respir J 2008, 32:740-747.
6. Sanderson K., Wescombe L., Kirov S.M., Champion A., Reid D.W. Bacterial cyanogenesis occurs in the cystic fibrosis lung. Eur Respir J 2008, 32:329-333.
7. Carterson A.J., Morici L.A., Jackson D.W., Frisk A., Lizewski S.E., Jupiter R., et al. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J Bacteriol 2004, 186:6837-6844.
8. Williams H.D., Zlosnik J.E., Ryall B. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa. Adv Microb Physiol 2007, 52:1-71.
9. Broderick K.E., Chan A., Balasubramanian M., Feala J., Reed S.L., Panda M., et al. Cyanide produced by human isolates of Pseudomonas aeruginosa contributes to lethality in Drosophila melanogaster. J Infect Dis 2008, 197:457-464.
10. Blumer C., Haas D. Iron regulation of the hcnABC genes encoding hydrogen cyanide synthase depends on the anaerobic regulator ANR rather than on the global activator GacA in Pseudomonas fluorescens CHA0. Microbiology 2000, 146(Pt 10):2417-2424.
11. Voisard C., Keel C., Haas D., Defago G. Cyanide production by Pseudomonas fluorescens helps suppress black root rot of tobacco under gnotobiotic conditions. EMBO J 1989, 8:351-358.
12. Knowles C.J., Bunch A.W. Microbial cyanide metabolism. Adv Microb Physiol 1986, 27:73-111.
13. Wissing F. Cyanide formation from oxidation of glycine of Pseudomonas species. J Bacteriol 1974, 117:1289-1294.
14. Castric P.A. Hydrogen cyanide production by Pseudomonas aeruginosa at reduced oxygen levels. Can J Microbiol 1983, 29:1344-1349.
15. Blumer C., Haas D. Mechanism, regulation, and ecological role of bacterial cyanide biosynthesis. Arch Microbiol 2000, 173:170-177.
16. Laville J., Blumer C., Von Schroetter C., Gaia V., Defago G., Keel C., et al. Characterization of the hcnABC gene cluster encoding hydrogen cyanide synthase and anaerobic regulation by ANR in the strictly aerobic biocontrol agent Pseudomonas fluorescens CHA0. J Bacteriol 1998, 180:3187-3196.
17. Pessi G., Haas D. Transcriptional control of the hydrogen cyanide biosynthetic genes hcnABC by the anaerobic regulator ANR and the quorum-sensing regulators LasR and RhlR in Pseudomonas aeruginosa. J Bacteriol 2000, 182:6940-6949.
18. Laville J., Voisard C., Keel C., Maurhofer M., Defago G., Haas D. Global control in Pseudomonas fluorescens mediating antibiotic synthesis and suppression of black root rot of tobacco. Proc Natl Acad Sci U S A 1992, 89:1562-1566.
19. Gregory E.M., Goscin S.A., Fridovich I. Superoxide dismutase and oxygen toxicity in a eukaryote. J Bacteriol 1974, 117:456-460.
20. Hariharakrishnan J., Satpute R.M., Prasad G.B., Bhattacharya R. Oxidative stress mediated cytotoxicity of cyanide in LLC-MK2 cells and its attenuation by alpha-ketoglutarate and N-acetyl cysteine. Toxicol Lett 2009, 185:132-141.
21. Williams P., Camara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol 2009, 12:182-191.
22. Cody W.L., Pritchett C.L., Jones A.K., Carterson A.J., Jackson D., Frisk A., et al. Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner. J Bacteriol 2009, 191:2993-3002.
23. Pessi G., Haas D. Dual control of hydrogen cyanide biosynthesis by the global activator GacA in Pseudomonas aeruginosa PAO1. FEMS Microbiol Lett 2001, 200:73-78.
24. Storey D.G., Ujack E.E., Rabin H.R. Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis. Infect Immun 1992, 60:4687-4694.
25. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002, 109:317-325.
26. Zlosnik J.E., Williams H.D. Methods for assaying cyanide in bacterial culture supernatant. Lett Appl Microbiol 2004, 38:360-365.
27. Son M.S., Matthews W.J., Kang Y., Nguyen D.T., Hoang T.T. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun 2007, 75:5313-5324.
28. Firoved A.M., Deretic V. Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J Bacteriol 2003, 185:1071-1081.
29. Hoiby N. Cystic fibrosis: infection. Schweiz Med Wochenschr 1991, 121:105-109.
30. Cooper M., Tavankar G.R., Williams H.D. Regulation of expression of the cyanide-insensitive terminal oxidase in Pseudomonas aeruginosa. Microbiology 2003, 149:1275-1284.
31. Matsushita K., Yamada M., Shinagawa E., Adachi O., Ameyama M. Membrane-bound respiratory chain of Pseudomonas aeruginosa grown aerobically. A KCN-insensitive alternate oxidase chain and its energetics. J Biochem 1983, 93:1137-1144.
32. Zlosnik J.E., Tavankar G.R., Bundy J.G., Mossialos D., O'Toole R., Williams H.D. Investigation of the physiological relationship between the cyanide-insensitive oxidase and cyanide production in Pseudomonas aeruginosa. Microbiology 2006, 152:1407-1415.
33. Cipollone R., Bigotti M.G., Frangipani E., Ascenzi P., Visca P. Characterization of a rhodanese from the cyanogenic bacterium Pseudomonas aeruginosa. Biochem Biophys Res Commun 2004, 325:85-90.
34. Tunney M.M., Field T.R., Moriarty T.F., Patrick S., Doering G., Muhlebach M.S., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008, 177:995-1001.
35. Schumacher A., Trittler R., Bohnert J.A., Kummerer K., Pages J.M., Kern W.V. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother 2007, 59:1261-1264.
36. Nelson L. Acute cyanide toxicity: mechanisms and manifestations. J Emerg Nurs 2006, 32:S8-S11.
37. Beasley D.M., Glass W.I. Cyanide poisoning: pathophysiology and treatment recommendations. Occup Med (Lond) 1998, 48:427-431.
38. Baud F.J., Borron S.W., Bavoux E., Astier A., Hoffman J.R. Relation between plasma lactate and blood cyanide concentrations in acute cyanide poisoning. BMJ 1996, 312:26-27.
39. Mokhlesi B., Leikin J.B., Murray P., Corbridge T.C. Adult toxicology in critical care: part II: specific poisonings. Chest 2003, 123:897-922.
40. Baud F.J. Cyanide: critical issues in diagnosis and treatment. Hum Exp Toxicol 2007, 26:191-201.
41. Musshoff F., Schmidt P., Daldrup T., Madea B. Cyanide fatalities: case studies of four suicides and one homicide. Am J Forensic Med Pathol 2002, 23:315-320.
42. Ryall B., Lee X., Zlosnik J.E., Hoshino S., Williams H.D. Bacteria of the Burkholderia cepacia complex are cyanogenic under biofilm and colonial growth conditions. BMC Microbiol 2008, 8:108.
43. Jones A.M., Dodd M.E., Govan J.R., Barcus V., Doherty C.J., Morris J., et al. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004, 59:948-951.
44. Sylvester M., Sander C. Immunohistochemical localization of rhodanese. Histochem J 1990, 22:197-200.
45. Cipollone R., Ascenzi P., Tomao P., Imperi F., Visca P. Enzymatic detoxification of cyanide: clues from Pseudomonas aeruginosa Rhodanese. J Mol Microbiol Biotechnol 2008, 15:199-211.
46. Cipollone R., Frangipani E., Tiburzi F., Imperi F., Ascenzi P., Visca P. Involvement of Pseudomonas aeruginosa rhodanese in protection from cyanide toxicity. Appl Environ Microbiol 2007, 73:390-398.
47. Nagahara N., Ito T., Minami M. Mercaptopyruvate sulfurtransferase as a defense against cyanide toxication: molecular properties and mode of detoxification. Histol Histopathol 1999, 14:1277-1286.
48. Cottrell J.E., Casthely P., Brodie J.D., Patel K., Klein A., Turndorf H. Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. N Engl J Med 1978, 298:809-811.
49. Wood J.L. Nutritional and protective properties of thiocystine. Proc Soc Exp Biol Med 1980, 165:469-472.
50. Milla C.E. Nutrition and lung disease in cystic fibrosis. Clin Chest Med 2007, 28:319-330.
51. Watt A.P., Courtney J., Moore J., Ennis M., Elborn J.S. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 2005, 60:659-664.
52. Downey D.G., Bell S.C., Elborn J.S. Neutrophils in cystic fibrosis. Thorax 2009, 64:81-88.
53. Borregaard N., Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982, 70:550-557.
54. Fossati G., Moulding D.A., Spiller D.G., Moots R.J., White M.R., Edwards S.W. The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol 2003, 170:1964-1972.
55. DesLauriers C.A., Burda A.M., Wahl M. Hydroxocobalamin as a cyanide antidote. Am J Ther 2006, 13:161-165.
56. Herant M., Heinrich V., Dembo M. Mechanics of neutrophil phagocytosis: experiments and quantitative models. J Cell Sci 2006, 119:1903-1913.
57. May R.C., Machesky L.M. Phagocytosis and the actin cytoskeleton. J Cell Sci 2001, 114:1061-1077.
58. Patriarca P., Dri P., Kakinuma K., Rossi F. Studies on the mechanism of metabolic stimulation in polymorphonuclear leukocytes during phagocytosis. Activators and inhibitors of the granule bound NADPH oxidase. Mol Cell Biochem 1976, 12:137-146.
59. Weiss S.J., LoBuglio A.F., Kessler H.B. Oxidative mechanisms of monocyte-mediated cytotoxicity. Proc Natl Acad Sci U S A 1980, 77:584-587.
60. DeChatelet L.R., McPhail L.C., Shirley P.S. Effect of cyanide on NADPH oxidation by granules from human polymorphonuclear leukocytes. Blood 1977, 49:445-454.
61. McGrath L.T., Mallon P., Dowey L., Silke B., McClean E., McDonnell M., et al. Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax 1999, 54:518-523.
62. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., Collins C.E., Garg M.L. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001, 20:157-165.
63. Reid D.W., Misso N., Aggarwal S., Thompson P.J., Walters E.H. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis. Respirology 2007, 12:63-69.
64. Herlin T., Borregaard N. Early changes in cyclic AMP and calcium efflux during phagocytosis by neutrophils from normals and patients with chronic granulomatous disease. Immunology 1983, 48:17-26.
65. Hall A.H., Dart R., Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning?. Ann Emerg Med 2007, 49:806-813.
66. Borron S.W., Baud F.J., Barriot P., Imbert M., Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007, 49(794-801):e1-e2.
67. Broderick K.E., Balasubramanian M., Chan A., Potluri P., Feala J., Belke D.D., et al. The cobalamin precursor cobinamide detoxifies nitroprusside-generated cyanide. Exp Biol Med (Maywood) 2007, 232:789-798.
68. Signoretto C., Bianchi F., Burlacchini G., Canepari P. Microbiological evaluation of the effects of hyperbaric oxygen on periodontal disease. New Microbiol 2007, 30:431-437.
69. Plafki C., Peters P., Almeling M., Welslau W., Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med 2000, 71:119-124.
70. Spanel P., Wang T., Smith D. Quantification of hydrogen cyanide in humid air by selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2004, 18:1869-1873.
71. Enderby B., Smith D., Carroll W., Lenney W. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol 2009, 44:142-147.
72. Minarowski L., Sands D., Minarowska A., Karwowska A., Sulewska A., Gacko M., et al. Thiocyanate concentration in saliva of cystic fibrosis patients. Folia Histochem Cytobiol 2008, 46:245-246.
73. Carroll W., Lenney W., Wang T., Spanel P., Alcock A., Smith D. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol 2005, 39:452-456.
74. Blumer C., Heeb S., Pessi G., Haas D. Global GacA-steered control of cyanide and exoprotease production in Pseudomonas fluorescens involves specific ribosome binding sites. Proc Natl Acad Sci U S A 1999, 96:14,073-14,078.
75. Green J.N., Winterbourn C.C., Hampton M.B. Analysis of neutrophil bactericidal activity. Methods Mol Biol 2007, 412:319-332.
76. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998, 92:3007-3017.